Sorting nexins (SNX) represent a diverse family of proteins involved in crucial cellular processes, particularly the regulation of intracellular membrane trafficking and sorting. SNX proteins play a pivotal role in orchestrating the endocytic and recycling pathways within cells, ensuring the precise localization and transport of various membrane-bound cargo proteins. Structurally, SNX proteins are characterized by the presence of one or more phosphoinositide-binding domains, most notably the Phox homology (PX) domain, which enables their association with specific phospholipids in cellular membranes. SNX proteins act as molecular adaptors that interact with other cellular components, such as clathrin, to facilitate the formation of membrane vesicles and the selective sorting of cargo molecules. By recognizing distinct sorting signals in cargo proteins, SNX proteins contribute to the proper routing of cargo between different membrane compartments, including endosomes, lysosomes, the trans-Golgi network, and the plasma membrane. Moreover, SNX proteins can engage in intricate protein-protein interactions with other cellular factors, including GTPases, to modulate membrane dynamics and cellular responses.
Sorting Nexin (SNX) Inhibitors are designed to interfere with the activity or interactions of SNX proteins within the cellular trafficking machinery. These inhibitors serve as valuable tools in research to dissect the roles of SNX proteins and their contributions to membrane dynamics and cargo sorting processes. Some SNX inhibitors may target the phosphoinositide-binding domains of SNX proteins, disrupting their membrane localization and impeding their ability to bind to specific lipids. Others may interfere with protein-protein interactions involving SNX proteins, their association with cargo molecules, adaptors, or other regulatory factors.
VER TAMBIÉN ....
| Nombre del producto | NÚMERO DE CAS # | Número de catálogo | Cantidad | Precio | MENCIONES | Clasificación |
|---|---|---|---|---|---|---|
Hydroxy-Dynasore | 1256493-34-1 | sc-364678 | 10 mg | $250.00 | ||
Este compuesto también inhibe la dinamina y, por tanto, puede interrumpir la endocitosis, lo que podría afectar al ciclo de PSGL1 en los endosomas. | ||||||
Apilimod | 541550-19-0 | sc-480051 sc-480051A | 100 mg 1 g | $420.00 $2600.00 | 5 | |
El apilimod es un inhibidor de la fosfoinositida 3-cinasa (PI3K) y se ha descrito que afecta indirectamente a SNX1 y SNX2, que participan en el tráfico endosomal y la remodelación de la membrana. | ||||||
Rasagiline | 136236-51-6 | sc-204875 sc-204875A | 25 mg 100 mg | $101.00 $210.00 | ||
La rasagilina es un inhibidor de la monoaminooxidasa B (MAO-B) y se ha demostrado que afecta a SNX7, un miembro de la familia SNX, alterando potencialmente los procesos de clasificación endosomal. | ||||||
Autophagy Inhibitor, 3-MA | 5142-23-4 | sc-205596 sc-205596A | 50 mg 500 mg | $56.00 $256.00 | 113 | |
La 3-MA inhibe la PI3K, que se sabe que afecta a la autofagia. Dada la relación entre endosomas y autofagosomas, la expresión de SNX33 podría verse influida. | ||||||
Niclosamide | 50-65-7 | sc-250564 sc-250564A sc-250564B sc-250564C sc-250564D sc-250564E | 100 mg 1 g 10 g 100 g 1 kg 5 kg | $37.00 $77.00 $184.00 $510.00 $1224.00 $5814.00 | 8 | |
La niclosamida inhibe SNX8 al interferir con su papel en la señalización Wnt, lo que conduce a la interrupción de la clasificación de la carga endosomal. | ||||||
GW4869 | 6823-69-4 | sc-218578 sc-218578A | 5 mg 25 mg | $199.00 $599.00 | 24 | |
GW4869 inhibe la esfingomielinasa, alterando la composición lipídica de los endosomas e interfiriendo en los procesos de clasificación mediados por SNX8. | ||||||
KPT185 | 1333151-73-7 | sc-487916 | 10 mg | $220.00 | ||
SAR405 inhibe la PI3-quinasa, interrumpiendo las vías de señalización de fosfoinositidos implicadas en la clasificación de carga endosomal mediada por SNX8. | ||||||
URMC-099 | 1229582-33-5 | sc-492603 | 5 mg | $143.00 | ||
PF-543 inhibe SphK1, alterando el metabolismo de los esfingolípidos y afectando indirectamente a los procesos de clasificación endosomal mediados por SNX8. | ||||||